Formulation of Biotech Products, Including Biopharmaceutical Considerations-Reference-Cited by-同舟云学术

Formulation of Biotech Products, Including Biopharmaceutical Considerations

Published:2013 Issue: Volume: Page:69-99
ISSN:
Container-title:Pharmaceutical Biotechnology
language:
Short-container-title:

Author:

Crommelin Daan J. A.

Publisher

Springer New York

Link

http://link.springer.com/content/pdf/10.1007/978-1-4614-6486-0_4

Reference69 articles.

1. Alzet product information (2012) http://www.alzet.com/products/ALZET_Pumps/index.html

2. Arakawa T, Kita Y, Carpenter JF (1991) Protein-solvent interactions in pharmaceutical formulation. Pharm Res 8:285–291

3. Bae YH, Park K (2011) Targeted drug delivery to tumors: myths, reality and possibility. J Control Release 153:198–205

4. Banerjee PS, Hosny EA, Robinson JR (1991) Parenteral delivery of peptide and protein drugs. In: Lee VHL (ed) Peptide and protein drug delivery. Marcel Dekker, Inc., New York, pp 487–543

5. Björk E, Edman P (1988) Characterization of degradable starch microspheres as a nasal delivery system for drugs. Int J Pharm 62:187–192

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gender and Ethnic Disparities of Acute Kidney Injury in COVID-19 Infected Patients: A Literature Review;Frontiers in Cellular and Infection Microbiology;2022-01-13

2. Potential and Applications of Nanocarriers for Efficient Delivery of Biopharmaceuticals;Pharmaceutics;2020-12-06

3. Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer’s disease;Translational Psychiatry;2020-02-03

4. Insights on the Formulation of Recombinant Proteins;Current Applications of Pharmaceutical Biotechnology;2019

5. Glypican-based drug releasing titania implants to regulate BMP2 bioactivity as a potential approach for craniosynostosis therapy;Nanomedicine: Nanotechnology, Biology and Medicine;2018-10